Paper 11 - MIR-449A/340 REWIRE METABOLIC COMMITMENT OF FUSION-NEGATIVE RHABDOMYOSARCOMA VIA MITOCHONDRIAL PYRUVATE CARRIER INHIBITION

Author(s)

• 

  Enrico Pozzo, MD, PhD

  Post-doc
  Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven; Leuven Cancer Institute (LKI)
  Leuven, Vlaams-Brabant, Belgium

  Slides

Co-Author(s)

• 

  Laura Yedigaryan, Master, PhD student (she/her/hers)

  PhD Student
  Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• NG

  Nefele Giarratana, PhD

  Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• 

  Chao-Chi Wang, PhD student (she/her/hers)

  PhD student
  Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute
  Leuven, Vlaams-Brabant, Belgium
• GM

  Gabriel Miró Garrido, n/a

  Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• ED

  Ewoud Degreef, n/a

  Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• VM

  Vittoria Marini, Master, PhD student

  Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• GR

  Gianmarco Rinaldi, PhD

  Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI)
  Leuven, Vlaams-Brabant, Belgium
• BV

  Bernard Van der Veer, Master, PhD student

  Laboratory of Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• GS

  Gabriele Sassi, Master, PhD student

  Clinical and Experimental Endocrinology (CEE), KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• GE

  Guy Eelen, PhD

  Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, Leuven
  Leuven, Vlaams-Brabant, Belgium
• MP

  Mélanie Planque, n/a

  Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI)
  Leuven, Vlaams-Brabant, Belgium
• AF

  Alessandro Fanzani, PhD

  Department of Molecular and Translational Medicine, University of Brescia
  Brescia, Lombardia, Italy
• KK

  Kian Peng Koh, PhD

  Laboratory of Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium
• PC

  Peter Carmeliet, MD, PhD

  Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, Leuven
  Leuven, Vlaams-Brabant, Belgium
• JY

  Jason Yustein, MD, PhD

  Aflac Cancer and Blood Disorders Center, Emory University
  Atlanta, Georgia, United States
• SF

  Sarah-Maria Fendt, PhD

  Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI)
  Leuven, Vlaams-Brabant, Belgium
• AU

  Anne Uyttebroeck, MD, PhD

  Department of Pediatric Hemato-Oncology, UZ Leuven
  Leuven, Vlaams-Brabant, Belgium
• 

  Maurilio Sampaolesi, PhD

  Professor and Head of Research Unit
  Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology Unit, Department of Development and Regeneration, KU Leuven
  Leuven, Vlaams-Brabant, Belgium